DailyDoctor Archive Specialties Get app
All orthopaedics briefings

The edition · Orthopaedics

The fragility fractures you cannot see on the radiograph are the ones killing people

Two JBJS reviews land together on the same problem from opposite ends: vertebral and pelvic insufficiency fractures that go undiagnosed, and a global care gap that is a health-system failure rather than an evidence one. Plus inflammatory markers and fracture risk, and digital rehabilitation that is finally ready for knee osteoarthritis.

The edition in brief

Two reviews in the Journal of Bone and Joint Surgery frame today's edition around fragility fracture. The first addresses vertebral compression and pelvic insufficiency fractures: common, associated with raised mortality and morbidity, frequently asymptomatic or attributed elsewhere, and hard to see on plain radiographs, particularly in the pelvis and sacrum. Non-operative care suits most patients, with surgery reserved for intractable pain, poor function, radiographic deterioration or neurological deficit, and secondary prevention treated as essential rather than optional. The second review argues that worldwide, fragility fracture care falls short of evidence that is not in dispute — timely surgery, orthogeriatric care, early mobilisation, unrestricted weight-bearing and secondary prevention. In low- and middle-income countries the constraint is workforce, delayed presentation, infrastructure and fragmented pathways, not a lack of evidence. A systematic review and meta-analysis of 48 observational studies found C-reactive protein associated with hip fracture (pooled ratio 1.39, 95% CI 1.17 to 1.67) and vertebral fracture (2.16, 1.47 to 3.18), interleukin-6 with hip fracture (1.40, 1.15 to 1.71) and TNF-alpha or its soluble receptors (1.81, 1.34 to 2.44), all at low GRADE certainty, and the authors are explicit that these must not replace established fracture-risk assessment. A GRADE-appraised review of extended reality found interactive digital rehabilitation improved pain-related functioning in knee osteoarthritis (SMD −0.59, 95% CI −1.11 to −0.06) with no adverse event signal, while evidence after total knee arthroplasty remains thin. And a small Indian trial of a standardised Boswellia serrata extract reported reduced WOMAC scores from day 7 without publishing the effect sizes.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for orthopaedics, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free